跳至主要内容
临床试验/IRCT138810273043N1
IRCT138810273043N1已完成未知

Effect of Pentoxifylline on Proteinuria in Patients with Membranous Nephropathy

Tehran University of Medical Sciences0 个研究点目标入组 46 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
46

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
14 years 至 65 years(—)
性别
All

入选标准

  • Inclusion Criteria: New cases with biopsy proven Membranous Nephropathy, Initial Random urine protein (mg/dl) > 2 g/day based on 24-hr urine collection

排除标准

  • Pregnancy, Breast feeding, Diabetes Mellitus, History of allergy to Pentoxifylline or any derivatives of methyl xanthenes, Cerebral hemorrhage or Retinal hemorrhage within the past 6 months prior to signing the informed consent form, Congestive heart failure (NYHA functional class III or IV), Uncontrolled hypertension (SBP > 200 mmHg and/or DBP > 110 mmHg), history of unstable angina, myocardial infarction, cerebrovascular accidents, Stroke, Obstructive uropathy, Cirrhosis, Hepatic dysfunction as defined by the following laboratory parameters: ALT or AST > 5 times the upper limit of the normal range, or > 3 times concomitant with signs and symptoms of hepatic failure

研究者

相似试验